BKHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends November 30Also trades as BKHAR, BKHAU

Black Hawk Acquisition Corp

Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 6, 2026

$4.03−1.98 (-32.95%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

Black Hawk Acquisition Corp balance sheet

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-11-30	FY 2024 2024-11-30	FY 2023 2023-11-30
Cash & Equivalents	0	0.26	0.13
Cash & Short-Term Investments	0	0.26	0.13
Prepaid Expenses & Other	0.01	0.05	–
Total Current Assets	0.05	0.31	0.16
Intangible Assets	5.00	–	–
Total Assets	24	72	0.26
Accounts Payable	0.30	–	–
Accrued Expenses	0	0	–
Total Current Liabilities	1.48	0.07	0.26
Total Liabilities	3.90	2.49	0.26
Common Stock	0.00	–	–
Additional Paid-In Capital	0.00	–	0.02
Retained Earnings	-3.85	-2.17	-0.02
Shareholders' Equity	-3.85	-2.17	0.01
Total Equity	-3.85	-2.17	0.01
Total Liabilities & Equity	24	72	0.26
Deposits	0.69	0.69	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Aug 31, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -44.2%

Financial strength

Current ratio: 0.02
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 0.0%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –